“One
in 10 American Adults is Diabetic; 1 in 4 is Unaware’ is the
full title of this recent story in DiabetesinControl.com.
The subtitle is “The United States has 3 million more diabetic patients today
than in 2010.” These shocking headlines are all too familiar, and frightening,
especially to the growing at-risk segment of the population. Is there any new
news here?
“According
to the 2014 National Diabetes Statistics Report, recently released by the
Centers for Disease Control, at least 29 million people living in the U.S. have
diabetes; 28% of these patients are undiagnosed. In a study done from 2009 to
2012, 37% of adults in the U. S. were considered pre-diabetic based on fasting
glucose and A1c levels. This equates to 86 million Americans who will become
diabetic if something doesn’t change.”
Of the pre-diabetics, only 7% know their status.
“…if
something doesn’t change.” Hmmm… So what does the medical and public health
establishment propose to do?
“Therefore,
the American College of Cardiology (ACC,) in collaboration with the American
Diabetes Association, the American College of Physicians and Joslin Diabetes
Center, has announced a partnership and the launch of a new Diabetes
Collaborative Registry that will help practitioners work together to track and
improve the quality of care across the continuum.” In other words, close ranks,
collect data, and hope, by studying
the data, to improve patient outcomes…
So, who’s
sponsoring, supporting and funding this new registry of patients? You guessed
it. AstraZeneca, makers of Byetta, Bydureon, Onglyza, and a host of other
pharmacotherapies, like Crestor, for diabetes and its related co-morbidities.
The goal: to “allow primary care physicians and specialists who treat patients
with diabetes to compare data and real-time metrics on patients in all stages
of the disease.” Access to electronic medical records; now that’s doing
something, huh?
The
president and CEO of the Joslin Diabetes Center summed it up nicely. He said,
the “center is pleased to be a founding partner of the first clinical diabetes
registry. Not only will patients benefit with a registry of this kind; so will
diabetes researchers who will gain access to numerous data from a variety of
specialists. This will ensure that research is based on the most current data
that is out there.” Did you miss how the patient will benefit? I did too.
He doesn’t say.
But maybe
the ACC guy does. The ACC president “believes there is a clear need for
cross-specialty management of diabetes patients especially because
cardiovascular disease is the leading cause of death for diabetic patients,”
according to the Diabetes in Control
piece. True enough. The ACC is a stakeholder in gaining access to your
electronic medical records too.
Maybe the
American Diabetes Association will be able to tell us how the patient will
benefit – how something will change
to prevent or deter or just slow down the rate at which, by the CDC’s Division
of Diabetes Translation (?!) predicts “if we do nothing, and the numbers
continue to rise, 1 in 5 Americans will have diabetes by 2025, and possibly 1
in 3 by 2050.”
Well,
here’s what the Diabetes Association’s Chief Scientific and Medical Officer
told Diabetes in Control: “Diabetes
is not one disease but a complex set of diseases and too often leads to serious
and potentially life-threatening complications, such as cardiovascular and
kidney disease, as well as nerve damage, amputation, blindness and a multitude
of other health problems. We hope
that a cross-specialty, clinical registry will ultimately allow us to improve
the quality of care – and therefore quality of life – for all people living
with diabetes by giving researchers a clearer picture of what’s happening to
patients at various stages of their disease. Improved data collection should
help us to improve patient outcomes.”
Well, there
you have it. Everyone wants to sit back and let researchers study the data “to
get a clearer picture of what’s happening to patients at various stages of
their disease,” like 86 million guinea pigs in one giant lab. I wonder why –
no, I am dumbfounded that – no one responded proactively to the CDC’s warning,
that “…if something doesn’t change… 86 million Americans will become diabetic.”
Let’s see. What could possibly change to affect this outcome? Diet, do ya
think?
Are the
American College of Cardiology (ACC), the American Diabetes Association, the
American College of Physicians and Joslin Diabetes Center all too hobbled by
their vested interest in, and dependence on, pharmacotherapy? Do they have any interest in, or curiosity about, a proven therapy that doesn’t
involve taking any drugs?
The medical
establishment is moving very slowly, and I’ve given up on our government doing
“something.” The purpose of the United States Department of Agriculture (USDA)
is to promote American agricultural and the food processing and manufacturing
industries. And they are the ones who ordain what we eat; they write the
Dietary Guidelines for Americans. The fox is in charge of the henhouse. So, what can you do to manage diabetes or
stave off pre-diabetes? Keep reading.
Analysts have increased new bits of knowledge into how raised glucose levels harm veins. High glucose levels diminish the degrees of the fantastic vasodilator nitric oxide in veins, a deficit that builds the danger of hypertension and limits the vessels in the extended run.
ReplyDelete